Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Nervous System Bacterial Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03418441
What this trial is testing

Central Nervous System Infections in Denmark

Who this might be right for
Central Nervous System InfectionsBacterial MeningitisViral Meningitis+9 more
Aalborg University Hospital 1,900
Testing effectiveness (Phase 2)Study completedNCT01802502
What this trial is testing

Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation

Who this might be right for
Tuberculous Meningitis
Universitas Padjadjaran 30
Not applicableStudy completedNCT06720519
What this trial is testing

Molecular Panel Evaluation for Diagnosis of Infections of the Central Nervosous System

Who this might be right for
Infections Nervous System
IRCCS Azienda Ospedaliero-Universitaria di Bologna 170
Large-scale testing (Phase 3)Study completedNCT00325130
What this trial is testing

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 1,042
Not applicableStudy completedNCT03244917
What this trial is testing

Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias

Who this might be right for
DementiaInfection, Bacterial
Hebrew SeniorLife 430
Large-scale testing (Phase 3)Study completedNCT03891758
What this trial is testing

Confirmatory Study of BK1310 in Healthy Infants

Who this might be right for
TetanusDiphtheriaPertussis+2 more
Tanabe Pharma Corporation 267
Post-approval studies (Phase 4)Study completedNCT00753649
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants

Who this might be right for
Hepatitis BTetanusPoliomyelitis+3 more
GlaxoSmithKline 224
Not applicableUnknownNCT00942006
What this trial is testing

Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis

Who this might be right for
Suspected Early Lyme Neuroborreliosis
University Medical Centre Ljubljana 200
Testing effectiveness (Phase 2)Study completedNCT00780806
What this trial is testing

Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults

Who this might be right for
Meningitis, Meningococcal
Wyeth is now a wholly owned subsidiary of Pfizer 60
Testing effectiveness (Phase 2)Study completedNCT01239043
What this trial is testing

Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi 139
Testing effectiveness (Phase 2)Study completedNCT00000776
What this trial is testing

Dexamethasone in Cryptococcal Meningitis

Who this might be right for
Meningitis, CryptococcalHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Large-scale testing (Phase 3)Study completedNCT02428491
What this trial is testing

Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 354
Large-scale testing (Phase 3)Study completedNCT06700148
What this trial is testing

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Year Olds

Who this might be right for
Meningococcal Meningitis
CanSino Biologics Inc. 840
Not applicableStudy completedNCT00146835
What this trial is testing

Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine

Who this might be right for
Hepatitis BPoliomyelitisDiphtheria+2 more
GlaxoSmithKline 120,794
Not applicableStudy completedNCT03595761
What this trial is testing

Meningitis With Cerebral Vasculitis in Children

Who this might be right for
Bacterial Meningitis
University Hospital, Montpellier 17
Large-scale testing (Phase 3)Ended earlyNCT00303082
What this trial is testing

Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity

Who this might be right for
Bacterial VaginosisPremature BirthSepsis+2 more
Oswaldo Cruz Foundation 645
Not applicableStudy completedNCT04939350
What this trial is testing

Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021

Who this might be right for
Cirrhosis
Centre Hospitalier Sud Francilien 742
Testing effectiveness (Phase 2)Study completedNCT01434680
What this trial is testing

Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy Toddlers

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis 992
Testing effectiveness (Phase 2)Study completedNCT01732627
What this trial is testing

Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections+1 more
Sanofi Pasteur, a Sanofi Company 301
Next Page